← Insider buys

ATEC

Alphatec Holdings, Inc. · Healthcare

Insiders bought $2.0M of Alphatec Holdings, Inc. in the last 12 months

2 insiders bought on 2 days.

$2.0MBought, 12 mo
$65.5MSold, 12 mo
$1.6BMarket cap

ATEC over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

ATEC after insider buys

3 months after each buy, from the first price a copier could get.

−4.9%Average
−12.5 ptsVs S&P 500
2 of 6Higher

6 buys since 2019 with 3 months of prices.

Every filing

148 insider filings since 2016, newest first

ATECSell

David Sponsel · EVP, Sales

$38KDec 26
ATECSell

Patrick Miles · CEO

$2.3M−3.0%Sep 27
ATECSell

Patrick Miles · CEO

$2.4M−3.0%Sep 20
ATECSell

James L L Tullis · Director

$1.5M−6.0%Sep 13
ATECSell

David H Mowry · Director

$137K−9.0%Sep 13
ATECSell

Evan Bakst · Director

$130K−1.0%Aug 24
ATECBuy

Jennifer N. Pritzker · 10% owner

$87KAug 10
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$1.9M−9.0%Jun 28
ATECSell

Elizabeth Ann Altman · Director

$150K−23.0%Jun 20
ATECSell

David Sponsel · EVP, Sales

$899K−9.0%Jun 20
ATECSell

Paul Segal · Director

$1.1M−1.0%Jun 16
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$890K−5.0%May 16
ATECSell

L-5 Healthcare Partners, LLC · Director by deputization, 10%

$25.3M−13.0%May 12
ATECSell

Paul Segal · 10% owner

$2.5M−1.0%May 12
ATECBuy

Jennifer N. Pritzker · 10% owner

$87KMay 11
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$449K−2.0%Apr 24
ATECSell

John Todd Koning · CFO

$271K−4.0%Apr 24
ATECBuy

David R Pelizzon · Director and 10% owner

$47KMar 15
ATECSell

Patrick Miles · CEO

$2.1M−2.0%Mar 13
ATECSell

James L L Tullis · Director

$484K−2.0%Mar 9
ATECBuy

Jennifer N. Pritzker · 10% owner

$72KMar 8
ATECSell

David Sponsel · EVP, Sales

$266K−2.0%Mar 8
ATECSell

Patrick Miles · CEO

$1.9M−3.0%Mar 8
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$525K−2.0%Mar 3
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$2.0M−9.0%Mar 1
ATECSell

Scott Lish · SVP, Development

$374K−5.0%Mar 1
ATECSell

John Todd Koning · CFO

$332K−5.0%Mar 1
ATECSell

John Todd Koning · CFO

$186K−3.0%Feb 23
ATECSell

Scott Lish · SVP, Development

$314K−5.0%Feb 23
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$923K−4.0%Feb 21
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$840K−4.0%Feb 10
ATECSell

Patrick Miles · CEO

$2.4M−3.0%Jan 24
ATECSell

Patrick Miles · CEO

$2.4M−3.0%Jan 19
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$504K−3.0%Jan 10
ATECSell

David Sponsel · EVP, Sales

$120K−2.0%Jan 10
ATECSell

James L L Tullis · Director

$530K−3.0%Dec 20
ATECSell

David Sponsel · EVP, Sales

$99K−2.0%Dec 5
ATECSell

David Sponsel · EVP, Sales

$93K−2.0%Nov 9
ATECSell

David H Mowry · Director

$34K−5.0%Aug 29
ATECSell

Elizabeth Ann Altman · Director

$73K−17.0%Aug 17
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$389K−3.0%Aug 17
ATECBuy

Jennifer N. Pritzker · 10% owner

$65KAug 11
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$429K−4.0%Jun 15
ATECSell

Craig E Hunsaker · EVP, People, Culture, GC

$501K−5.0%Jun 3
ATECSell

Patrick Miles · CEO

$2.4M−5.0%May 20
ATECBuy

Jennifer N. Pritzker · 10% owner

$48KMay 17
ATECSell

James L L Tullis · Director

$900K−3.0%Apr 11
ATECBuy

Jennifer N. Pritzker · 10% owner

$46KMar 10
ATECSell

Scott Lish · SVP, Development

$56K−2.0%Mar 3
ATECSell

Scott Lish · SVP, Development

$46K−2.0%Feb 24
About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.